All In Biotech

Drug Trial Radar · NCT03996291

Long Term Safety and Efficacy Study of Tolebrutinib (SAR442168) in Participants With Relapsing Multiple Sclerosis

Long-term Extension Safety and Efficacy Study of SAR442168 in Participants With Relapsing Multiple Sclerosis

Last checked: Nov 20, 2026Latest source record: Oct 23, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

125

Actual

Start

Sep 23, 2019

Primary completion

Nov 26, 2024

Study completion Nov 26, 2024

Sponsor

Lead sponsor
SanofiSanofi (SNY)
Sponsor type
Industry
First posted
Jun 24, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Primary Objective: To determine the long-term safety and tolerability of SAR442168 in RMS participants Secondary Objective: To evaluate efficacy of SAR442168 on disease activity, assessed by clinical and imaging methods

Conditions

  • Relapsing Multiple Sclerosis

Interventions

  • TolebrutinibDrug

    Pharmaceutical form: Film coated tablet Route of administration: Oral

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Treatment-emergent Adverse Events (TEAEs) and Treatment-emergent Serious Adverse Events (TESAEs)Time frame: From first dose of study drug (Day 1) up to maximum exposure, 39 weeks in Part A and 222 weeks in Part B

Locations

37 sites in 9 countries. Site status is shown where the registry gives one.

  • North Central Neurology Associates, PC Site Number : 8400005

    Cullman, Alabama

  • Neurology Associates, PA Site Number : 8400002

    Maitland, Florida

  • University of South Florida Site Number : 8400009

    Tampa, Florida

  • Velocity Clinical Research Site Number : 8400007

    Savannah, Georgia

  • Consultants In Neurology Site Number : 8400001

    Northbrook, Illinois

  • UC Health, LLC Site Number : 8400008

    Dayton, Ohio

  • MDH Research LLC Site Number : 8400006

    Westerville, Ohio

  • Neurology PC Site Number : 8400003

    Knoxville, Tennessee

  • Investigational Site Number : 1240003

    Vancouver, British Columbia, Canada

  • Investigational Site Number : 1240001

    Greenfield Park, Quebec, Canada

  • Investigational Site Number : 2030007

    Brno, Czechia

  • Investigational Site Number : 2030004

    Hradec Králové, Czechia

  • Investigational Site Number : 2030003

    Jihlava, Czechia

  • Investigational Site Number : 2030005

    Ostrava - Poruba, Czechia

  • Investigational Site Number : 2030006

    Pardubice, Czechia

  • Investigational Site Number : 2030001

    Prague, Czechia

  • Investigational Site Number : 2030002

    Praha 5 - Motol, Czechia

  • Investigational Site Number : 2330001

    Tallinn, Estonia

  • Investigational Site Number : 2500004

    Nancy, France

  • Investigational Site Number : 5280001

    Amsterdam, Netherlands

  • Investigational Site Number : 6430006

    Kazan', Russia

  • Investigational Site Number : 6430003

    Moscow, Russia

  • Investigational Site Number : 6430005

    Saint Petersburg, Russia

  • Investigational Site Number : 6430001

    Saint Petersburg, Russia

  • Investigational Site Number : 6430007

    Tyumen, Russia

  • Investigational Site Number : 7240001

    Madrid, Spain

  • Investigational Site Number : 7240004

    Murcia, Spain

  • Investigational Site Number : 7240003

    Seville, Andalusia, Spain

  • Investigational Site Number : 7240002

    Barcelona, Barcelona [Barcelona], Spain

  • Investigational Site Number : 7240005

    Salt, Girona [Gerona], Spain

  • Investigational Site Number : 8040002

    Chernivtsi, Ukraine

  • Investigational Site Number : 8040005

    Dnipro, Ukraine

  • Investigational Site Number : 8040001

    Lviv, Ukraine

  • Investigational Site Number : 8040006

    Lviv, Ukraine

  • Investigational Site Number : 8040009

    Odesa, Ukraine

  • Investigational Site Number : 8040003

    Vinnytsia, Ukraine

  • Investigational Site Number : 8040007

    Zhytomyr, Ukraine

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.